Aligos Therapeutics Inc (NASDAQ:ALGS)
| 0.7435 Delayed Data As of 3:59pm ET |  +0.0145 / +1.99%Today’s Change | 0.71 Today|||52-Week Range 2.41 | -21.98% Year-to-Date |
Latest ALGS News | Press Releases
No recent news for Aligos Therapeutics Inc.
Today’s Trading
| Previous close | 0.73 |
| Today’s open | 0.76 |
| Day’s range | 0.74 - 0.76 |
| Volume | 69 |
| Average volume (3 months) | 95,548 |
| Market cap | $33.1M |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +30.13% |
| Earnings growth (this year) | +18.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +219.04% |
| P/E ratio | NM |
| Price/Sales | 2.93 |
| Price/Book | 0.31 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $13.9M |
| Annual profit (last year) | -$96.0M |
| Net profit margin | -690.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
